Company: DMAAR
Filing Date: 2025-11-18
Form Type: 8-K
Source: 0001213900-25-111704
Chunk: 1

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 8-K
Item: Item 5.02
Chunk 1
---
 offering. The Indemnity Agreement, Letter Agreement and Registration Rights
Agreement will be in the forms of the agreement that are filed as exhibits to the Company’s Annual Report on Form 10-K, which was
filed with the U. S. Securities and Exchange Commission. Other than the foregoing, Mr. Elmasri is not party to any arrangement or understanding
with any person pursuant to which he was appointed as an executive officer of the Company, nor is he party to any transactions required
to be disclosed under Item 404(a) of Regulation S-K involving the Company. There are no family relationships between Mr. Elmasri and
any of the Company’s directors and executive officers.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Dated:
November 17, 2025

  DRUGS                                                     
  By:                                    /s/                
  Name:                                  Lynn               
  Title:                                 Chief